High-grade acute organ toxicity as positive prognostic factor in primary radio(chemo)therapy for locally advanced, inoperable head and neck cancer

Strahlentherapie und Onkologie

Volumn 186, Issue 5, 2010, Pages 262-268

  Wolff, Hendrik Andreas ^a   Bosch, Jan ^a   Jung, Klaus ^a   Overbeck, Tobias ^a   Hennies, Steffen ^a   Matthias, Christoph ^a   Hess, Clemens F ^a   Roedel, Ralph M ^a   Christiansen, Hans ^a  

^a UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Locally advanced squamous cell head neck cancer; Prognosis; Radio(chemo)therapy; Toxicity

Indexed keywords

CISPLATIN; FLUOROURACIL; MITOMYCIN C; ANTINEOPLASTIC AGENT; MITOMYCIN;

ANEMIA; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER SURVIVAL; CONTINUOUS INFUSION; DYSPHAGIA; FEMALE; HEAD AND NECK CARCINOMA; HEAD AND NECK SQUAMOUS CELL CARCINOMA; HUMAN; LEUKOPENIA; MAJOR CLINICAL STUDY; MALE; MUCOSA INFLAMMATION; OUTCOME ASSESSMENT; PROGNOSIS; SKIN MANIFESTATION; SURVIVAL RATE; SURVIVAL TIME; THROMBOCYTOPENIA; TREATMENT RESPONSE; CANCER STAGING; DISEASE COURSE; HEAD AND NECK TUMOR; METHODOLOGY; MORTALITY; MULTIMODALITY CANCER THERAPY; PATHOLOGY; RADIATION DOSE; RADIOTHERAPY; RETROSPECTIVE STUDY; SURVIVOR; TIME; TREATMENT OUTCOME;

ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; DISEASE PROGRESSION; FLUOROURACIL; HEAD AND NECK NEOPLASMS; HUMANS; MITOMYCIN; NEOPLASM STAGING; PROGNOSIS; RADIOTHERAPY; RADIOTHERAPY DOSAGE; RETROSPECTIVE STUDIES; SURVIVORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 77952785992     PISSN: 01797158     EISSN: 1439099X     Source Type: Journal    
DOI: 10.1007/s00066-010-2136-z     Document Type: Article

References (23)

1. D.J. Adelstein Y. Li G.L. Adams, et al. 2003 An Intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer J Clin Oncol 21 92 98 10.1200/JCO.2003.01.008 12506176
2. P. Balermpas M. Hambek O. Seitz, et al. 2009 Combined cetuximab and reirradiation for locoregional recurrent and inoperable squamous cell carcinoma of the head and neck Strahlenther Onkol 185 775 781 10.1007/s00066-009-2092-7 20013086
3. J.A. Bonner P.M. Harari J. Giralt, et al. 2010 Radiotherapy plus cetuximab for locoregionally advanced head and neck cancer: 5-year survival data from a phase 3 randomised trial, and relation between cetuximab-induced rash and survival Lancet Oncol 11 21 28 10.1016/S1470-2045(09)70311-0 1:CAS:528:DC%2BC3cXjslKktA%3D%3D 19897418
4. K. Borgmann U. Hoeller S. Nowack, et al. 2008 Individual radiosensitivity measured with lymphocytes may predict the risk of acute reaction after radiotherapy Int J Radiat Oncol Biol Phys 71 256 264 18406889
5. G.P. Browman D.I. Hodson R.J. Mackenzie, et al. 2001 Choosing a concomitant chemotherapy and radiotherapy regimen for squamous cell head and neck cancer: a systematic review of the published literature with subgroup analysis Head Neck 23 579 589 10.1002/hed.1081 1:STN:280:DC%2BD3MzjtFyntg%3D%3D 11400247 (Pubitemid 32565532)
6. J.D. Cox J. Stetz T.F. Pajak 1995 Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC) Int J Radiat Oncol Biol Phys 31 1341 1346 1:STN:280:DyaK2M3ivFCrsA%3D%3D 7713792
7. J. Cuzick I. Sestak D. Cella L. Fallowfield 2008 Treatment-emergent endocrine symptoms and the risk of breast cancer recurrence: a retrospective analysis of the ATAC trial Lancet Oncol 9 1143 1148 10.1016/S1470-2045(08)70259- 6 1:CAS:528:DC%2BD1cXhsVWrsL7J 18976959
8. O. Dahl A. Horn O. Mella 1994 Do acute side-effects during radiotherapy predict tumour response in rectal carcinoma? Acta Oncol 33 409 413 10.3109/02841869409098437 1:STN:280:DyaK2c3ovFSmsg%3D%3D 8018374
9. G. de Castro Jr I.M. Snitcovsky E.M. Gebrim, et al. 2007 High-dose cisplatin concurrent to conventionally delivered radiotherapy is associated with unacceptable toxicity in unresectable, non-metastatic stage IV head and neck squamous cell carcinoma Eur Arch Otorhinolaryngol 264 1475 1482 10.1007/s00405-007-0395-9 17643256 (Pubitemid 350112409)
10. E.J. Franzmann D.S. Lundy A.A. Abitbol W.J. Goodwin 2006 Complete hypopharyngeal obstruction by mucosal adhesions: a complication of intensive chemoradiation for advanced head and neck cancer Head Neck 28 663 670 10.1002/hed.20392 16783832 (Pubitemid 44116890)
11. B. Jeremic B. Milicic A. Dagovic, et al. 2004 Radiation therapy with or without concurrent low-dose daily chemotherapy in locally advanced, nonmetastatic squamous cell carcinoma of the head and neck J Clin Oncol 22 3540 3548 10.1200/JCO.2004.10.076 15337803 (Pubitemid 41103660)
12. T. Kuhnt C. Richter H. Enke J. Dunst 1998 Acute radiation reaction and local control in breast cancer patients treated with postmastectomy radiotherapy Strahlenther Onkol 174 257 261 10.1007/BF03038718 1:STN:280: DyaK1c3nslWmuw%3D%3D 9614954
13. U.A. Patel K.H. Thakkar N. Holloway 2008 Patient compliance to radiation for advanced head and neck cancer at a tertiary care county hospital Laryngoscope 118 428 432 10.1097/MLG.0b013e31815ae3d2 18043491 (Pubitemid 351640614)
14. J.P. Pignon J. Bourhis C. Domenge L. Designe 2000 Chemotherapy added to locoregional treatment for head and neck squamous-cell carcinoma: three meta-analyses of updated individual data. MACH-NC Collaborative Group. Meta-Analysis of Chemotherapy on Head and Neck Cancer Lancet 355 949 955 1:STN:280:DC%2BD3c3ivV2iuw%3D%3D 10768432
15. D. Rades F. Fehlauer M. Sheikh-Sarraf, et al. 2008 Toxicity of two cisplatin-based radiochemotherapy regimens for the treatment of patients with stage III/IV head and neck cancer Head Neck 30 235 241 10.1002/hed.20683 17657790 (Pubitemid 351251708)
16. 2 in 103 head-and-neck cancer patients: a cumulative dose-effect analysis Strahlenther Onkol 185 682 688 10.1007/s00066-009-1989-5 19806334
17. H. Strasser G.G. Grabenbauer C.N. Sprung, et al. 2007 DNA double-strand break induction and repair in irradiated lymphoblastoid, fibroblast cell lines and white blood cells from ATM, NBS and radiosensitive patients Strahlenther Onkol 183 447 453 10.1007/s00066-007-1683-4 17680225 (Pubitemid 47240931)
18. Y. Tang Y. Zhang L. Guo, et al. 2008 Relationship between individual radiosensitivity and radiation encephalopathy of nasopharyngeal carcinoma after radiotherapy Strahlenther Onkol 184 510 514 10.1007/s00066-008-1898-z 19016039
19. S. Tribius S. Kronemann Y. Kilic, et al. 2009 Radiochemotherapy including cisplatin alone versus cisplatin + 5-fluorouracil for locally advanced unresectable stage IV squamous cell carcinoma of the head and neck Strahlenther Onkol 185 675 681 10.1007/s00066-009-1992-x 19806333
20. A. Trotti R. Byhardt J. Stetz, et al. 2000 Common Toxicity Criteria: version 2.0. An improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy Int J Radiat Oncol Biol Phys 47 13 47 1:STN:280:DC%2BD3c3itlCjsg%3D%3D 10758303
21. A. Trotti A.D. Colevas A. Setser, et al. 2003 CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment Semin Radiat Oncol 13 176 181 10.1016/S1053-4296(03)00031-6 12903007 (Pubitemid 36962641)
22. H.A. Wolff J. Gaedcke K. Jung, et al. 2010 High-grade acute organ toxicity during preoperative radiochemotherapy as positive predictor for complete histopathologic tumor regression in multimodal treatment of locally advanced rectal cancer Strahlenther Onkol 186 30 35 10.1007/s00066-009-2037-1 20082185
23. Wolff HA, Raus I, Jung K, et al. High-grade acute organ toxicity as positive prognostic factor in primary radiochemotherapy for anal carcinoma. Int J Radiat Oncol Biol Phys 2010:in press.